Fonar (FONR) Competitors $15.88 +0.06 (+0.38%) Closing price 04:00 PM EasternExtended Trading$15.86 -0.02 (-0.09%) As of 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. SMTI, CLPT, NPCE, TCMD, BWAY, SKIN, DRTS, CATX, OM, and TLSIShould you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Sanara MedTech (SMTI), ClearPoint Neuro (CLPT), NeuroPace (NPCE), Tactile Systems Technology (TCMD), Brainsway (BWAY), Beauty Health (SKIN), Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), Outset Medical (OM), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. Fonar vs. Its Competitors Sanara MedTech ClearPoint Neuro NeuroPace Tactile Systems Technology Brainsway Beauty Health Alpha Tau Medical Perspective Therapeutics Outset Medical TriSalus Life Sciences Sanara MedTech (NASDAQ:SMTI) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations. Do analysts rate SMTI or FONR? Sanara MedTech currently has a consensus price target of $50.00, indicating a potential upside of 48.24%. Given Sanara MedTech's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sanara MedTech is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Fonar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SMTI or FONR more profitable? Fonar has a net margin of 8.19% compared to Sanara MedTech's net margin of -10.22%. Fonar's return on equity of 5.31% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.22% -26.43% -10.69% Fonar 8.19%5.31%3.97% Which has better valuation and earnings, SMTI or FONR? Fonar has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.46-$9.66M-$1.16-29.08Fonar$102.88M0.96$10.57M$1.2512.70 Do institutionals & insiders have more ownership in SMTI or FONR? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 50.6% of Fonar shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by insiders. Comparatively, 1.6% of Fonar shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility & risk, SMTI or FONR? Sanara MedTech has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Fonar has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Does the media favor SMTI or FONR? In the previous week, Sanara MedTech had 4 more articles in the media than Fonar. MarketBeat recorded 5 mentions for Sanara MedTech and 1 mentions for Fonar. Fonar's average media sentiment score of 1.87 beat Sanara MedTech's score of 0.86 indicating that Fonar is being referred to more favorably in the news media. Company Overall Sentiment Sanara MedTech Positive Fonar Very Positive SummaryFonar beats Sanara MedTech on 9 of the 16 factors compared between the two stocks. Get Fonar News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.46M$10.59B$5.76B$9.84BDividend YieldN/A1.86%3.95%4.02%P/E Ratio12.7021.6931.3126.60Price / Sales0.9630.57461.30121.37Price / Cash5.0024.9437.7659.36Price / Book0.643.5110.026.67Net Income$10.57M$210.11M$3.27B$265.59M7 Day Performance4.34%5.11%3.17%3.42%1 Month Performance-0.50%11.53%4.34%1.09%1 Year Performance-8.37%-6.20%44.11%23.85% Fonar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFonar2.562 of 5 stars$15.88+0.4%N/A-8.7%$98.46M$102.88M12.70480SMTISanara MedTech2.0325 of 5 stars$32.93-3.0%$50.00+51.8%+0.4%$302.23M$86.67M-28.3960CLPTClearPoint Neuro2.1153 of 5 stars$10.50-1.9%$19.67+87.3%-16.5%$298.48M$33.59M-12.96110Positive NewsNPCENeuroPace3.0093 of 5 stars$8.65-3.8%$16.60+91.9%+13.6%$297.40M$79.91M-10.30170TCMDTactile Systems Technology2.4358 of 5 stars$13.00-1.7%$13.50+3.8%+0.1%$294.92M$292.98M20.971,037Positive NewsBWAYBrainsway3.0454 of 5 stars$15.36+1.1%$18.00+17.2%+89.8%$287.31M$41.02M59.08120Analyst ForecastSKINBeauty Health1.5907 of 5 stars$2.10-5.0%$2.63+25.0%+13.9%$280.28M$334.30M-7.501,030DRTSAlpha Tau Medical3.0423 of 5 stars$3.21+1.6%$9.00+180.4%+51.8%$268.03MN/A-6.6980News CoveragePositive NewsCATXPerspective Therapeutics1.3837 of 5 stars$3.46-6.0%$12.56+262.9%-76.4%$256.95MN/A0.0070OMOutset Medical1.3518 of 5 stars$13.72-3.4%$24.67+79.8%+43.6%$252.28M$119.30M-0.68520TLSITriSalus Life Sciences3.134 of 5 stars$4.93-2.4%$10.75+118.1%-5.0%$251.83M$29.43M-4.18106 Related Companies and Tools Related Companies Sanara MedTech Competitors ClearPoint Neuro Competitors NeuroPace Competitors Tactile Systems Technology Competitors Brainsway Competitors Beauty Health Competitors Alpha Tau Medical Competitors Perspective Therapeutics Competitors Outset Medical Competitors TriSalus Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fonar Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Fonar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access